MindMed discovers, develops and deploys psychedelic inspired medicines to alleviate suffering and improve health.
MindMed is advancing and building a compelling pipeline of psychedelic inspired medicines through clinical trials.
MindMed will continue to expand its pipeline & IP over the next 6-12 months through:
• Co-Development Agreements
• In-Licensing with leading academic research institutions of. existing & new clinical research in psychedelics
• Proprietary clinical trials with new psychedelics
